PsiOxus Therapeutics Ltd. (PsiOxus) and the Parker Institute for Cancer Immunotherapy (Parker Institute) announce a research project to investigate the use of PsiOxus’ virus-based gene therapy for treating solid tumors… read more →
June 4, 2018 – Philadelphia, PA and Oxford, UK – PsiOxus Therapeutics, Ltd. (PsiOxus), a leader in gene therapy for cancer, today announced the appointment of Melissa Epperly as Chief Financial Officer.… read more →
The Sunday Times Hiscox Tech Track 100 league table ranks Britain’s 100 private tech (TMT) companies with the fastest-growing sales over their latest three years. It is compiled by Fast Track… read more →
DECEMBER 20th, 2016 – NEW YORK and OXFORD, UK – Bristol-Myers Squibb Company (NYSE: BMY) and PsiOxus Therapeutics, Ltd. (PsiOxus) today announced an agreement granting Bristol-Myers Squibb exclusive worldwide rights… read more →
